FathomX

FathomX’s flagship product, FxMammo, is an AI assistant for mammogram interpretation that has demonstrated high accuracy in detecting breast cancer, especially in dense breasts among Asian women. It reduces false positives and negatives compared to traditional readings, streamlines clinical workflow by reducing screening time and workforce needs, and is currently undergoing multi-site validation across eight Asia-Pacific markets. The company collaborates with leading institutions such as the National University of Singapore, National University Health System, Diagnostics Development Hub of A*STAR Singapore, Hewlett Packard Enterprise, and Japan’s National Cancer Center